Medicinal Products

Revlimid

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Revlimid
Active Substance lenalidomid
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L04AX04
Medicinal product marketed in the Croatia Trajni prekid opskrbe
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Vodič za zdravstvene radnike, verzija 4
Obrazac pristanka bolesnika, verzija 3
Obrazac prijave trudnoće, verzija 3
Educational materials
for patients / caregivers
Vodic za bolesnike, verzija 4
Kartica za bolesnika, verzija 3

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o novim važnim preporukama s obzirom na reaktivaciju virusa uz primjenu lenalidomida (Revlimid) 08.11.2016 Celgene Europe Limited
Back